Acer Therapeutics
(NASDAQ) ACER
Acer Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$371.79K
Net Income (TTM)
$48.49M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ACER News
ACER: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Acer Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
33
CEO
Christopher Schelling
Website
www.acertx.comHeadquarters
Newton, MA 02458, US
ACER Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
3%
Return on Capital
3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$24.61M
EBITDA
$24.55M
Operating Cash Flow
$30.25M
Capital Expenditure
$171.17K
Free Cash Flow
$30.42M
Cash & ST Invst.
$2.33M
Total Debt
$11.86M
Acer Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$371.79K
N/A
Gross Profit
$287.99K
N/A
Gross Margin
77.46%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
30
N/A
Net Income
$14.73M
-195.3%
EBITDA
$12.88M
-131.6%
Quarterly Fundamentals
Net Cash
$17.56M
-838.5%
Accounts Receivable
$0.00
N/A
Inventory
$5.20M
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$18.15M
+1101.7%
Return on Assets
-2.26%
N/A
Return on Invested Capital
3.36%
N/A
Free Cash Flow
$16.00M
-75.9%
Operating Cash Flow
$16.00M
-76.0%